Pam Brick

Which therapy more effectively prevents COPD exacerbations: dual bronchodilation with a long-acting beta agonist and a long-acting antimuscarinic agent, or LABA/ICS?

Does influenza vaccination protect patients hospitalized for diabetes against the risk for poor outcomes and complications?

In patients with sepsis and atrial fibrillation, how does treatment with phenylephrine vs norepinephrine affect heart rate?

Can older adults who are critically ill with COVID-19 safely use tocilizumab, an IL-6 inhibitor with potential immunosuppressive effects?

Investigators in Poland assessed the feasibility of lung transplantation for patients with irreversible respiratory failure due to severe COVID-19.

Final evidence from the WHO Solidarity clinical trials shows that remdesivir has only a slight protective effect and only among certain patients with COVID-19.

How often do ICS/LABA drugs reach the correct receptors in individuals with COPD? Researchers analyzed drug deposition and reception patterns in 2 drug therapies.

A phase 2 study assessed safety and immunogenicity of administering a high-dose quadrivalent influenza vaccine with a mRNA-1273 vaccine booster dose in older adults.

Is VTE risk unusually high in patients with COVID-19? To find out, researchers compared VTE incidence in inpatients with COVID-19 vs those with CAP.

The CanCOLD study assessed linkage between high VE/VCO2, dyspnea, and exercise capacity, as well as the link between high V̇E/V̇CO2 and lung function impairment.